<p><h1>Legal Cannabis for Medical Use Market Size Growing and Forecasted for period from 2024 - 2031 and provides complete market analysis of this market</h1></p><p><strong>Legal Cannabis for Medical Use Market Analysis and Latest Trends</strong></p>
<p><p>Legal cannabis for medical use refers to the regulation and legalization of the consumption, possession, and distribution of cannabis or its derivatives for medical purposes. It involves the use of cannabis products to alleviate symptoms and treat various medical conditions under the supervision of healthcare professionals.</p><p>The market for legal cannabis for medical use has witnessed significant growth in recent years. The increasing awareness about the therapeutic benefits of cannabis, along with the growing acceptance of its medical use, has been the key driving factor. Moreover, the expanding patient pool suffering from chronic pain, neurological disorders, cancer, and other conditions has contributed to the market's growth.</p><p>Various countries and states have implemented legislative reforms to legalize medical cannabis, creating new market opportunities. The United States, Canada, Germany, Australia, and several other countries have established regulatory frameworks to facilitate the legal production and sale of cannabis-based medicines. This has led to the emergence of licensed dispensaries and pharmacies specializing in medical cannabis, along with the growth of pharmaceutical companies focusing on the development of cannabis-derived drugs.</p><p>The legal cannabis for medical use market has also witnessed several trends. One notable trend is the increasing preference for cannabis oil and extracts over traditional forms of consumption like smoking. This shift can be attributed to the perceived health risks associated with smoking and the convenience of cannabis oils.</p><p>Furthermore, there is a growing demand for CBD (cannabidiol) products due to their potential therapeutic benefits without psychoactive effects. CBD is primarily used for pain management, anxiety relief, and as an anti-inflammatory agent. The market has seen the introduction of a wide range of CBD-infused products, including oils, tinctures, edibles, and topicals.</p><p>Overall, the legal cannabis for medical use market is expected to experience significant growth in the coming years. The forecasted 10.9% CAGR indicates a positive outlook, driven by the increasing acceptance of medical cannabis, favorable regulatory reforms, expanding patient pool, and evolving product preferences.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1262218">https://www.reliableresearchreports.com/enquiry/request-sample/1262218</a></p>
<p>&nbsp;</p>
<p><strong>Legal Cannabis for Medical Use Major Market Players</strong></p>
<p><p>The legal cannabis for medical use market has seen significant growth in recent years, and several players have emerged as key contenders in this industry. Some of the prominent players in the market include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis Inc, Canopy Growth Corporation, Insys Therapeutics Inc, Aphria Inc, MGC Pharmaceuticals Limited, GW Pharmaceuticals plc, Medical Marijuana Inc, and Medipharm Labs.</p><p>Aurora Cannabis Inc is one of the leading players in the legal cannabis market. The company operates a vertically integrated cannabis business, including cultivation, production, and distribution. Aurora has a strong market presence in Canada and has also expanded its operations globally. The company's revenue has been steadily increasing over the years and is expected to continue growing in the future. In the fiscal year 2019, Aurora reported net revenue of CAD 248.9 million.</p><p>Canopy Growth Corporation is another major player in the industry. It is one of the largest cannabis producers in the world and has a diverse product portfolio. Canopy Growth has a significant market share in Canada and has also expanded its operations in other countries. The company has experienced rapid revenue growth, reporting net revenue of CAD 226.3 million in the fiscal year 2019.</p><p>Medreleaf Corporation, which was acquired by Aurora Cannabis Inc in 2018, is a leading Canadian licensed producer of medical cannabis. Medreleaf has a strong market reputation for its premium quality cannabis products and has experienced substantial market growth. Although specific revenue figures are not available after the acquisition, Medreleaf reported net revenue of CAD 30.3 million in the fiscal year 2018.</p><p>Tilray is a global pioneer in the research, cultivation, production, and distribution of medical cannabis. The company operates in several countries, including Canada, Germany, Australia, and Portugal. Tilray's revenue has shown impressive growth, reaching USD 167.3 million in the fiscal year 2019, up from USD 43.1 million in the previous year.</p><p>The legal cannabis for medical use market is expected to witness significant growth in the coming years, driven by expanding legalization, increasing awareness among consumers, and growing acceptance of medical cannabis as a treatment option. According to a report by Grand View Research, the global medical cannabis market size was estimated at USD 13.4 billion in 2018 and is projected to expand at a CAGR of 23.9% from 2019 to 2025.</p><p>Overall, the landscape of the legal cannabis for medical use market is highly competitive, with several key players vying for market share. Companies like Aurora Cannabis, Canopy Growth, and Tilray have seen substantial growth in revenue and are well-positioned to capitalize on the expanding medical cannabis market.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Legal Cannabis for Medical Use Manufacturers?</strong></p>
<p><p>The legal cannabis for medical use market has been experiencing significant growth over the years due to the increasing acceptance and legalization of medical cannabis in various countries. The market is primarily driven by the growing demand for cannabis-based therapies for various medical conditions, such as chronic pain, cancer, and epilepsy. Additionally, the expanding geriatric population and the rising prevalence of chronic diseases further propel market growth. Looking ahead, the market is expected to witness favorable growth in the coming years, driven by increasing government initiatives, advancements in cultivation techniques, and the growing number of clinical trials exploring the efficacy of cannabis-based treatments.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1262218">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1262218</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Legal Cannabis for Medical Use Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Tetrahydrocannabinol (THC)</li><li>Cannabidiol (CBD)</li></ul></p>
<p><p>The legal cannabis for medical use market consists of different types, namely Tetrahydrocannabinol (THC) and Cannabidiol (CBD) markets. THC is the psychoactive component of cannabis, and products containing higher levels of THC are known for their intoxicating effects. On the other hand, CBD is a non-psychoactive component that provides potential therapeutic benefits without causing a high. Both markets cater to individuals seeking medical relief, but THC products are more suitable for those looking for psychoactive effects, while CBD products are preferred by those seeking therapeutic benefits without psychotropic sensations.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1262218">https://www.reliableresearchreports.com/purchase/1262218</a></p>
<p>&nbsp;</p>
<p><strong>The Legal Cannabis for Medical Use Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Cancer</li><li>Arthritis</li><li>Migraine</li><li>Epilepsy</li><li>Others</li></ul></p>
<p><p>The legal cannabis market for medical use encompasses various conditions such as cancer, arthritis, migraine, epilepsy, and others. Patients suffering from these conditions can benefit from the potential therapeutic properties of cannabis. Medical cannabis has been found to alleviate pain and inflammation associated with arthritis, relieve migraine symptoms and frequency, reduce seizures in epilepsy patients, and provide relief from the side effects of cancer treatments. This growing market offers potential solutions for individuals seeking alternative treatments for their medical conditions.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Legal Cannabis for Medical Use Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The legal cannabis market for medical use is experiencing significant growth in various regions. North America (NA) has been at the forefront, with a market share of over 45%, driven by favorable regulatory reforms in the United States (USA) and Canada. The Asia-Pacific (APAC) region is also witnessing a surge in demand, primarily due to the expanding patient pool and the gradual legalization of medical cannabis in countries like Australia. Europe holds substantial potential as well, with countries such as Germany and the Netherlands leading the market share, estimated at around 30%. Meanwhile, China's market share is anticipated to steadily grow, supported by increasing acceptance and the potential relaxation of regulations. Overall, NA and Europe are expected to dominate the market, collectively holding approximately 75% of the market share valuation.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1262218">https://www.reliableresearchreports.com/purchase/1262218</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1262218">https://www.reliableresearchreports.com/enquiry/request-sample/1262218</a></p>
<p><strong></strong></p>
<p>Check more reports on https://www.reliableresearchreports.com/</p>